ctDNA-guided adjuvant treatment after radical-intent treatment of metastatic spread from colorectal cancer-the first interim results from the OPTIMISE study.

Louise Bach Callesen,Torben Frøstrup Hansen,Rikke Fredslund Andersen,Niels Pallisgaard,Stine Kramer, Sven Schlander,Søren Rafael Rafaelsen,Anders Kindberg Boysen,Lars Henrik Jensen,Anders Jakobsen,Karen-Lise Garm Spindler

Acta oncologica (Stockholm, Sweden)（2023）

引用 0|浏览7

暂无评分

摘要

The study was proven to be feasible and continues in the planned large-scale phase II trial. Results from the OPTIMISE study will potentially optimize the adjuvant treatment of patients undergoing radical-intent treatment of mCRC, thereby improving survival and reducing chemotherapy-related toxicity.

查看译文

关键词

adjuvant treatment,colorectal cancer—the,metastatic,ctdna-guided,radical-intent

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要